The Role of Interleukin 22 in Multiple Sclerosis and Its Association With C-Maf and AHR

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia - Czech Republic
doi 10.5507/bp.2019.024
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Palacky University Olomouc

Related search

Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Interleukin-7 Expression and Its Effect on Natural Killer Cells in Patients With Multiple Sclerosis

Journal of Neuroimmunology
AllergyImmunologyNeurology
2014English

The Efficacy and Safety of Daclizumab and Its Potential Role in the Treatment of Multiple Sclerosis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2013English

Clinical Implications of C-Maf Expression in Plasma Cells From Patients With Multiple Myeloma

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2017English

Association of Retinal and Macular Damage With Brain Atrophy in Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Confirmation of Association Between Multiple Sclerosis and CYP27B1

European Journal of Human Genetics
Genetics
2010English

The Role of the Cerebellum in Multiple Sclerosis

Cerebellum
MedicineNeurology
2015English

A Catch-22: Interleukin-22 and Cancer

European Journal of Immunology
AllergyImmunology
2018English

Patient Perceptions of Multiple Sclerosis and Its Treatment

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy